Segall Bryant & Hamill LLC Takes Position in Adient $ADNT

Segall Bryant & Hamill LLC bought a new stake in Adient (NYSE:ADNTFree Report) during the 1st quarter, HoldingsChannel.com reports. The fund bought 69,461 shares of the company’s stock, valued at approximately $1,404,000.

Several other hedge funds have also recently made changes to their positions in ADNT. UBS Group AG lifted its position in Adient by 12.9% during the 4th quarter. UBS Group AG now owns 1,848,690 shares of the company’s stock worth $35,439,000 after acquiring an additional 210,758 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of Adient by 179.3% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 527,356 shares of the company’s stock valued at $10,658,000 after purchasing an additional 338,517 shares during the period. SG Americas Securities LLC increased its holdings in shares of Adient by 117.8% in the first quarter. SG Americas Securities LLC now owns 913,585 shares of the company’s stock valued at $18,464,000 after purchasing an additional 494,054 shares during the period. Principal Financial Group Inc. raised its stake in shares of Adient by 18.8% in the first quarter. Principal Financial Group Inc. now owns 448,624 shares of the company’s stock worth $9,067,000 after purchasing an additional 71,055 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership raised its stake in shares of Adient by 17.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,293,353 shares of the company’s stock worth $46,349,000 after purchasing an additional 336,306 shares during the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.

Adient Stock Performance

Shares of ADNT stock opened at $21.21 on Wednesday. Adient has a 52-week low of $17.68 and a 52-week high of $27.32. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. The stock has a market cap of $1.66 billion, a PE ratio of 29.88, a price-to-earnings-growth ratio of 0.41 and a beta of 1.52. The business has a 50-day simple moving average of $20.81 and a 200-day simple moving average of $21.61.

Adient (NYSE:ADNTGet Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.44 by $0.08. The firm had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.62 billion. Adient had a return on equity of 7.28% and a net margin of 0.39%.Adient’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the company earned $0.69 earnings per share. On average, equities analysts expect that Adient will post 2.13 EPS for the current year.

Insider Transactions at Adient

In other Adient news, EVP Heather M. Tiltmann sold 22,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $22.71, for a total value of $499,620.00. Following the sale, the executive vice president owned 110,886 shares in the company, valued at approximately $2,518,221.06. This represents a 16.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. UBS Group lifted their target price on Adient from $33.00 to $34.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. JPMorgan Chase & Co. reduced their price target on shares of Adient from $28.00 to $26.00 and set a “neutral” rating for the company in a research report on Thursday, April 23rd. Wells Fargo & Company lifted their price objective on shares of Adient from $28.00 to $32.00 and gave the company an “overweight” rating in a research note on Thursday, June 25th. Citigroup raised shares of Adient from a “neutral” rating to a “buy” rating and upped their price objective for the company from $30.00 to $33.00 in a report on Wednesday, April 15th. Finally, BNP Paribas Exane upgraded shares of Adient from a “neutral” rating to an “outperform” rating and set a $26.00 price objective on the stock in a research note on Thursday, July 30th. Six analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Adient has an average rating of “Hold” and a consensus target price of $27.90.

Check Out Our Latest Report on ADNT

About Adient

(Free Report)

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.

Recommended Stories

Want to see what other hedge funds are holding ADNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adient (NYSE:ADNTFree Report).

Institutional Ownership by Quarter for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.